TWC
IONS icon

TD Waterhouse Canada’s Ionis Pharmaceuticals IONS Stock Holding History

TD Waterhouse Canada’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8K Hold
48
– – ﹤0.01% 2039
2026
Q1 		$3.6K Buy
+48
New +$3.79K ﹤0.01% 1974
2022
Q4 		– Sell
-100
Closed -$4.5K – 1745
2022
Q3 		$4.5K Hold
100
– – ﹤0.01% 1378
2022
Q2 		$3.8K Hold
100
– – ﹤0.01% 1440
2022
Q1 		$3.88K Hold
100
– – ﹤0.01% 1497
2021
Q4 		$3.13K Buy
+100
New +$3.15K ﹤0.01% 1521

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

TD Waterhouse Canada's IONS Position: Q2 2026 in Review

TD Waterhouse Canada held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 48 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

TD Waterhouse Canada first reported a position in IONS in Q4 2021 and has held it in 6 quarters since. The position peaked at $4.5K in Q3 2022. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • TD Waterhouse Canada held 48 shares of Ionis Pharmaceuticals worth $3.8K as of Q2 2026.
  • TD Waterhouse Canada left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2039 holding.
  • TD Waterhouse Canada first reported a position in Ionis Pharmaceuticals in Q4 2021 and has held it in 6 quarters since.
  • TD Waterhouse Canada's Ionis Pharmaceuticals position peaked at $4.5K in Q3 2022.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.